Cargando…

Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening

OBJECTIVE: Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and recent developments in risk stratification, early-detection biomarkers, and diagnost...

Descripción completa

Detalles Bibliográficos
Autores principales: Keeney, Edna, Thom, Howard, Turner, Emma, Martin, Richard M., Sanghera, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079293/
https://www.ncbi.nlm.nih.gov/pubmed/33797744
http://dx.doi.org/10.1007/s40273-021-01009-6
_version_ 1783685196927729664
author Keeney, Edna
Thom, Howard
Turner, Emma
Martin, Richard M.
Sanghera, Sabina
author_facet Keeney, Edna
Thom, Howard
Turner, Emma
Martin, Richard M.
Sanghera, Sabina
author_sort Keeney, Edna
collection PubMed
description OBJECTIVE: Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and recent developments in risk stratification, early-detection biomarkers, and diagnostic technologies as a case study, we report a modified Delphi approach to handle decision-question uncertainty. METHODS: The study involved two rounds of anonymous online questionnaires to identify the prostate cancer screening strategies that international researchers, clinicians and decision makers felt important to consider in a cost-effectiveness model. Both purposive and snowball sampling were used to recruit experts. The questionnaire was based on a review of the literature and was piloted for language, comprehension and ease of use prior to dissemination. In Round 1, respondents indicated their preferred screening strategy (including no screening) through a series of multiple-choice questions. The responses informed a set of 13 consensus statements, which respondents ranked their agreement with on a 9-point Likert scale (Round 2). Consensus was considered reached if > 70% of participants indicated agreement and < 15% indicated disagreement. RESULTS: Twenty participants completed Round 1 and 17 completed Round 2. Consensus was shown towards comparing no formal screening, age-based, and risk-based strategies. The risk-based approaches included screening only higher-risk men, using shorter screening intervals for higher-risk men, screening higher-risk men at an earlier age, and tailoring screening intervals based on prostate-specific antigen (PSA) level at a previous test. There was agreement that inclusion of MRI in the pathway should be considered, but disagreement on the inclusion of new biomarkers. CONCLUSION: In disease areas where technologies are rapidly evolving, a modified Delphi approach provides a useful tool to identify relevant comparators in an economic evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40273-021-01009-6.
format Online
Article
Text
id pubmed-8079293
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80792932021-05-05 Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening Keeney, Edna Thom, Howard Turner, Emma Martin, Richard M. Sanghera, Sabina Pharmacoeconomics Original Research Article OBJECTIVE: Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and recent developments in risk stratification, early-detection biomarkers, and diagnostic technologies as a case study, we report a modified Delphi approach to handle decision-question uncertainty. METHODS: The study involved two rounds of anonymous online questionnaires to identify the prostate cancer screening strategies that international researchers, clinicians and decision makers felt important to consider in a cost-effectiveness model. Both purposive and snowball sampling were used to recruit experts. The questionnaire was based on a review of the literature and was piloted for language, comprehension and ease of use prior to dissemination. In Round 1, respondents indicated their preferred screening strategy (including no screening) through a series of multiple-choice questions. The responses informed a set of 13 consensus statements, which respondents ranked their agreement with on a 9-point Likert scale (Round 2). Consensus was considered reached if > 70% of participants indicated agreement and < 15% indicated disagreement. RESULTS: Twenty participants completed Round 1 and 17 completed Round 2. Consensus was shown towards comparing no formal screening, age-based, and risk-based strategies. The risk-based approaches included screening only higher-risk men, using shorter screening intervals for higher-risk men, screening higher-risk men at an earlier age, and tailoring screening intervals based on prostate-specific antigen (PSA) level at a previous test. There was agreement that inclusion of MRI in the pathway should be considered, but disagreement on the inclusion of new biomarkers. CONCLUSION: In disease areas where technologies are rapidly evolving, a modified Delphi approach provides a useful tool to identify relevant comparators in an economic evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40273-021-01009-6. Springer International Publishing 2021-04-02 2021 /pmc/articles/PMC8079293/ /pubmed/33797744 http://dx.doi.org/10.1007/s40273-021-01009-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Keeney, Edna
Thom, Howard
Turner, Emma
Martin, Richard M.
Sanghera, Sabina
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
title Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
title_full Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
title_fullStr Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
title_full_unstemmed Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
title_short Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
title_sort using a modified delphi approach to gain consensus on relevant comparators in a cost-effectiveness model: application to prostate cancer screening
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079293/
https://www.ncbi.nlm.nih.gov/pubmed/33797744
http://dx.doi.org/10.1007/s40273-021-01009-6
work_keys_str_mv AT keeneyedna usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening
AT thomhoward usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening
AT turneremma usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening
AT martinrichardm usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening
AT sangherasabina usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening